Weight Loss
US$ 21.82
gsk glp 1 agonist Frontiers GLP-1 receptor agonist 2 |
Description
K., Bao, R
Data analysed by one-way ANOVA, multiple comparison, Bonferroni post hoc test ( f , g , j , l - n , r and s ), two-way repeated measures ANOVA to assess main effects of treatment ( b , c , e and k ), and ANCOVA computed with calR using body weight as a covariate ( p )
Regarding its binding affinity, tirzepatide shows similar affinity for the human GIP receptor as native GIP (human GIP: Ki = 0.132 nM vs
doi: 10.4158/EP.17.6.906 226 LudvikBGiorginoFJdarEFriasJPFernndez LandLBrownKet al
